Mural Oncology

Mural Oncology, a spin out from Alkermes, is developing cytokine-based immunotherapies for the treatment of cancer.

paint mural street artist spray paint woman painting

Biotech

Mural's IL-2 flop triggers 90% staff reduction

Mural is laying off 90% of its employees and stopping clinical development of its lead program to hunker down and seek a strategic alternative.

Nick Paul Taylor Apr 15, 2025 9:33am

Jefferies Healthcare Conference London 2024

The JPM pregame: Jam-packed Jefferies conference makes its mark

Nov 19, 2024 11:00am

Pythagorean theorem

ASCO: It's back to the basics for cancer drug developers

Jun 5, 2024 10:55am

An artists rendering of cytokines being released from immune cells

AACR: Mural debuts data for potential pipeline additions

Apr 10, 2024 11:16am